133 related articles for article (PubMed ID: 24509452)
1. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.
Smith FM; Wiland H; Mace A; Pai RK; Kalady MF
Dis Colon Rectum; 2014 Mar; 57(3):311-5. PubMed ID: 24509452
[TBL] [Abstract][Full Text] [Related]
2. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy.
Agarwal A; Chang GJ; Hu CY; Taggart M; Rashid A; Park IJ; You YN; Das P; Krishnan S; Crane CH; Rodriguez-Bigas M; Skibber J; Ellis L; Eng C; Kopetz S; Maru DM
Cancer; 2013 Dec; 119(24):4231-41. PubMed ID: 24089344
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens.
de la Fuente SG; Manson RJ; Ludwig KA; Mantyh CR
J Gastrointest Surg; 2009 Feb; 13(2):269-74. PubMed ID: 18850250
[TBL] [Abstract][Full Text] [Related]
4. Split scar sign to predict complete response in rectal cancer after neoadjuvant chemoradiotherapy: systematic review and meta-analysis.
Torri GB; Wiethan CP; Langer FW; de Oliveira GS; Meirelles AVB; Horvat N; Tse JR; Dias AB; Altmayer S
Eur Radiol; 2024 Jun; 34(6):3874-3881. PubMed ID: 37979009
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of pathologic complete response for locally advanced rectal cancer.
Cloos AJ; Schissel M; Batra R; Donahue SR; Wenos CD; Kumar T; Leinicke JA; Thompson JS; Langenfeld SJ
Am J Surg; 2023 Dec; 226(6):873-877. PubMed ID: 37460372
[TBL] [Abstract][Full Text] [Related]
6. Pattern of Residual Submucosal Involvement after Neoadjuvant Therapy for Rectal Cancer: A Rationale for the Utility of Endoscopic Submucosal Resection.
Elazzamy H; Bhatt M; Mazzara P; Barawi M; Zeni A; Aref A
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893525
[No Abstract] [Full Text] [Related]
7. Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden.
Stockton JD; Tee L; Whalley C; James J; Dilworth M; Wheat R; Nieto T; ; Geh I; Barros-Silva JD; Beggs AD
Radiat Oncol; 2021 Jul; 16(1):129. PubMed ID: 34256782
[TBL] [Abstract][Full Text] [Related]
8. Loss of psoas muscle during neoadjuvant treatment for rectal cancer is associated with poor oncological and surgical outcomes.
Yassaie S; Lan R; Hodder R
ANZ J Surg; 2024 Jun; 94(6):1146-1150. PubMed ID: 38486418
[TBL] [Abstract][Full Text] [Related]
9. Distal spread and tumor regression patterns following preoperative chemoradiotherapy in rectal cancer patients.
Özer İ; Zengin Nİ; Çaycı HM; Yüksel A; Dalgıç T; Ulaş M; Bostancı EB; Akoğlu M
Turk J Med Sci; 2021 Dec; 51(6):2978-2985. PubMed ID: 34493029
[TBL] [Abstract][Full Text] [Related]
10. Complete response rates in rectal cancer: Temporal changes over a decade in a population-based nationwide cohort.
Temmink SJD; Martling A; Angenete E; Nilsson PJ
Eur J Surg Oncol; 2023 Nov; 49(11):106991. PubMed ID: 37495447
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Nodal Disease in Rectal Cancer Patients with Complete Mucosal Response to Neoadjuvant Therapy.
Emile SH; Maron DJ; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
World J Surg; 2023 Aug; 47(8):2013-2022. PubMed ID: 37084107
[TBL] [Abstract][Full Text] [Related]
12. Colostomy-site carcinoma with primitive phenotype in a rectal cancer patient after achieving pathological complete response with neoadjuvant chemoradiotherapy.
Kodama T; Kanzawa M; Hasegawa H; Tsukamoto S; Nishio M; Shigeoka M; Koma YI; Itoh T; Yokozaki H
Pathol Int; 2024 Jan; 74(1):33-38. PubMed ID: 38131501
[TBL] [Abstract][Full Text] [Related]
13. Gross morphologic features of surgical specimen in rectal cancer patients with pathological complete response following neoadjuvant chemoradiotherapy: A cross-sectional study.
Fazeli AR; Tadbir Vajargah K; Fazeli MS; Behboudi B; Ahmadi-Tafti SM; Kazemeini A; Keshvari A; Keramati MR
World J Surg; 2024 May; ():. PubMed ID: 38794790
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?
Rubio GA; Hurst RD; Umanskiy K; Shogan BD; Hyman N; Olortegui KS
J Gastrointest Surg; 2022 Feb; 26(2):479-482. PubMed ID: 34506020
[No Abstract] [Full Text] [Related]
15. Emerging trends in the prediction of pathological tumour response in rectal cancer following neoadjuvant therapy.
Wei MY; Arafat Y; Lee M; Kosmider S; Loft M; Faragher I; Gibbs P; Yeung JM
ANZ J Surg; 2023 Oct; 93(10):2285-2286. PubMed ID: 36716258
[No Abstract] [Full Text] [Related]
16. Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer - implications for the development of new imaging modalities for response assessment.
van der Stel SD; van den Berg JG; Snaebjornsson P; Seignette IM; Witteveen M; Grotenhuis BA; Beets GL; Post AL; Ruers TJM
Front Oncol; 2023; 13():1209732. PubMed ID: 37736547
[TBL] [Abstract][Full Text] [Related]
17. Case report: Pathological complete response of pregnancy associated pulmonary enteric adenocarcinoma to chemoradiotherapy.
Nemoto Y; Kuroda K; Oyama R; Mori M; Shimajiri S; Tanaka F
Front Oncol; 2024; 14():1290757. PubMed ID: 38463225
[TBL] [Abstract][Full Text] [Related]
18. Correction to: Split scar sign to predict complete response in rectal cancer after neoadjuvant chemoradiotherapy: systematic review and meta-analysis.
Torri GB; Wiethan CP; Langer FW; de Oliveira GS; Meirelles AVB; Horvat N; Tse JR; Dias AB; Altmayer S
Eur Radiol; 2024 Jan; ():. PubMed ID: 38240808
[No Abstract] [Full Text] [Related]
19. Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
Li J; Li L; Yang L; Yuan J; Lv B; Yao Y; Xing S
Oncotarget; 2016 Jul; 7(28):44857-44870. PubMed ID: 27070085
[TBL] [Abstract][Full Text] [Related]
20. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
